✦ LIBER ✦

Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study

✍ Scribed by Lawrence W. Elmer; Erwin Surmann; Babak Boroojerdi; Joseph Jankovic

Book ID: 116821164
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 408 KB
Volume: 18
Category: Article
ISSN: 1353-8020
DOI: 10.1016/j.parkreldis.2012.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and efficacy of rotigot

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study

✍ Wolfgang Oertel; Claudia Trenkwalder; Heike Beneš; Luigi Ferini-Strambi; Birgit 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 391 KB

P.5.a.006 Long-term safety and tolerabil

P.5.a.006 Long-term safety and tolerability of memantine: an open-label extension study in patients with mild to moderate Alzheimer's disease

✍ S. Bakchine; M. Rainer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Rotigotine transdermal system for the ma

Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study

✍ C. Trenkwalder; B. Kies; P. Dioszeghy; D. Hill; E. Surmann; B. Boroojerdi; J. Wh 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 371 KB

A 26-week, Open-label Extension Study Ev

A 26-week, Open-label Extension Study Evaluating The Long-term Safety And Tolerability Of Ciclesonide Hydrofluoroalkane Nasal Aerosol In Patients With Perennial Allergic Rhinitis

✍ Storms, W.; Gross, G.; Spector, S.; Huang, H.; Desai, S.Y. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Open-label flexible-dose pilot study to

Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease

✍ Joseph H. Friedman; Robert M. Berman; Christopher G. Goetz; Stewart A. Factor; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

## Abstract Psychosis affects at least 5% to 8% of medication‐treated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PD‐related motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr

Long-term efficacy and safety of ezetimi

Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study

✍ D. Lütjohann; K. Von Bergmann; W. Sirah; G. Macdonell; A. O. Johnson-Levonas; A. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB